Drug Substance Manufacturing for Viral Vaccines, Gene & Immune Therapeutics, Oncolytic Viruses and Viral Vectors
Products
Information
Drug Substance Manufacturing for pre-clinical, clinical and commercial supply- Validation of aseptic processes - Cell and virus banking - Using own seed cell banks: VERO and DF-1, Duck cell line (AGE-1) - API production using different TechnologiesMVA Know-How IDT Biologika is considered the global leader in MVA (Modified Vaccinia Ankara) and recombinant and non-recombinant poxvirus technologies and aseptic processing Contact us for more information
Distribution Areas
North America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
GermanyUnited States
All categories
Sera and VaccinesBiopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)APIs (Active Pharmaceutical Ingredients)Cell & Gene therapyInnovative APIsProductsServices
Main Categories
Biopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)APIs (Active Pharmaceutical Ingredients)
